Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
08/2012
08/09/2012WO2012104576A2 Carotenoid particles and uses thereof
08/09/2012WO2012104571A1 Compositions of monoterpenoids for the treatment of influenza
08/09/2012WO2012104570A1 Composition of monoterpenoids having bactericidal properties
08/09/2012WO2012104569A1 Composition of monoterpenoids for the treatment of cancer
08/09/2012WO2012104568A1 Compositions of monoterpenoids for stimulating the immune system
08/09/2012WO2012104567A1 Compositions of monoterpenoids for the treatment of an hiv infection
08/09/2012WO2012104464A1 Semi-solid bioadhesive system for the administration of active substance
08/09/2012WO2012104461A1 Development and use of polymer nanoparticles comprising poly(epsilon-caprolactone) and doxorubicin
08/09/2012WO2012104419A1 Hyaluronic acid composition
08/09/2012WO2012104277A2 Method of monitoring the release from liposomes of a product of interest using superparamagnetic nanoparticles.
08/09/2012WO2012104275A2 Nanoparticles delivery systems, preparation and uses thereof
08/09/2012WO2012103985A2 Pharmaceutical composition consisting of rna having alkali metal as counter ion and formulated with dications
08/09/2012WO2012103802A1 Liquid medicinal composition containing echinocandin antifungal agent micafungin
08/09/2012WO2012103801A1 Medicinal composition containing echinocandin antifungal agent micafungin, and preparation method and use therefor
08/09/2012WO2012103634A1 Cellulose-based nanoparticles for drug delivery
08/09/2012WO2012080176A3 Pharmaceutical compositions comprising alisporivir
08/09/2012WO2012078695A9 Dosage and administration for preventing cardiotoxicity in treatment with erbb2-targeted immunoliposomes comprising anthracyclin chemotherapeutic agents
08/09/2012WO2012076670A3 Antibody formulation
08/09/2012WO2012075253A3 Pharmaceutical compositions
08/09/2012WO2012071476A3 Drug eluting ocular implant
08/09/2012WO2012071389A3 Stable cannabinoid compositions and methods for making and storing them
08/09/2012WO2012070798A3 Topical antifungal composition comprising terbinafine or its salt
08/09/2012WO2012064305A3 Formulations comprising montelukast and levocetirizine
08/09/2012WO2012064304A3 Combinations comprising montelukast
08/09/2012WO2012056452A3 Pharmaceutical compositions and delivery devices comprising stinging cells or capsules
08/09/2012WO2012051374A3 Use of monoamine oxidase inhibitors to improve epithelial biology
08/09/2012WO2012048294A3 Pharmaceutical compositions for treating chronic pain and pain associated with neuropathy
08/09/2012WO2012042224A3 Pharmaceutical composition comprising deferasirox
08/09/2012WO2012031175A4 Nanoparticle-based tumor-targeted drug delivery
08/09/2012WO2012030309A3 Formulation of comprising tiotropium and a calcium channel blocker
08/09/2012WO2012030308A3 Formulation comprising cellobiose
08/09/2012WO2011115684A3 Lipid vesicle compositions and methods of use
08/09/2012WO2011059477A3 Methods and apparatus for mixing dairy animal treatment chemicals
08/09/2012US20120203356 Calcium sulfate composite particles including aggregated calcium sulfate nanoparticles and method of use for bone augmentation
08/09/2012US20120203212 Reduction of inflammatory mass with spinal catheters
08/09/2012US20120203050 Metallic nanoparticles, preparation and uses thereof
08/09/2012US20120202880 Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
08/09/2012US20120202879 Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
08/09/2012US20120202866 Buccal, polar and non-polar spray containing ondansetron
08/09/2012US20120202858 Solid Pharmaceutical Dosage Form
08/09/2012US20120202855 Methods for treating hyperlipidemia with intermediate release nicotinic acid compositions having unique biopharmaceutical characteristics
08/09/2012US20120202841 Topical Compositions Comprising Ascomycins
08/09/2012US20120202798 COMPOSITIONS CONTROLLING pH RANGE OF RELEASE AND/OR RELEASE RATE
08/09/2012US20120202743 SUSTAINED RELEASE FORMULATIONS COMPRISING GnRH ANALOGUES
08/09/2012US20120202742 Methods and devices for the sustained release of multiple drugs
08/09/2012US20120202695 Core stabilized microcapsules, method of their preparation and uses thereof
08/09/2012US20120202064 Poly(lactic-glycolic)acid cross linked alendronate (plga-aln) a short term controlled release system for stem cell differentiation and drug delivery
08/09/2012US20120201895 Pharmaceutical Compositions
08/09/2012US20120201894 Pharmaceutical formulations for the treatment of overactive bladder
08/09/2012US20120201893 Pellets Formulation
08/09/2012US20120201892 Porous-wall hollow glass microspheres as carriers for biomolecules
08/09/2012US20120201891 Transdermal delivery patch
08/09/2012US20120201890 Methods and compositions to support transplanted tissue integration and innosculation with adipose stromal cells
08/09/2012US20120201889 Modified and immediate release formulations of memantine
08/09/2012US20120201888 Pharmaceutical Compositions
08/09/2012US20120201887 Pharmaceutical Formulation
08/09/2012US20120201886 Coated Extended Release Pharmaceutical Compositions Containing Paliperidone
08/09/2012US20120201885 Pharmaceutical compositions of combinations of dipeptidyl peptidase-4 inhibitors with pioglitazone
08/09/2012US20120201884 Extracts, fractions and compositions comprising acetogenins and their applications
08/09/2012US20120201883 Antiviral compositons
08/09/2012US20120201882 Calcium carbonate granulation
08/09/2012US20120201881 Calcium carbonate granulation
08/09/2012US20120201880 Calcium carbonate granulation
08/09/2012US20120201879 Calcium carbonate granulation
08/09/2012US20120201878 Calcium carbonate granulation
08/09/2012US20120201877 Calcium Carbonate Granulation
08/09/2012US20120201876 Method of managing hypercortisolemia, headache disorders, neuropathic pain and related disorders
08/09/2012US20120201875 Stable low digestive enzyme content formulation
08/09/2012US20120201874 Liposome Having Inner Water Phase Containing Sulfobutyl Ether Cyclodextrin Salt
08/09/2012US20120201873 Controlled release formulations of lipocalin muteins
08/09/2012US20120201872 Liposomes comprising a calcium phosphate-containing precipitate
08/09/2012US20120201871 Permeation enhancers with liposomes for topical formulations
08/09/2012US20120201870 Dicalcium Phosphate Ceramics, Dicalcium Phosphate/Hydroxyapatite Biphasic Ceramics and Method of Manufacturing the Same
08/09/2012US20120201869 Marine bacterial substances, medical devices, and methods for biofilm inhibition
08/09/2012US20120201868 Treatment and prevention of hiv infection
08/09/2012US20120201867 Drug delivery from embolic agents
08/09/2012US20120201866 Cistus extracts
08/09/2012US20120201865 Hot-melt extruded compositions containing plant-derived phenolic materials and processes for the preparation thereof
08/09/2012US20120201864 Method
08/09/2012US20120201863 Methods for thickening hydrophobic liquids with amphiphilic esters
08/09/2012US20120201862 Process for the preparation of colloidal systems for the delivery of active compounds
08/09/2012US20120201860 Ultra-thin metal oxide and carbon-metal oxide films prepared by atomic layer deposition (ALD)
08/09/2012US20120201859 Drug Delivery Systems and Use Thereof
08/09/2012US20120201858 Multiple-arm peptide compounds, methods of manufacture and use in therapy
08/09/2012US20120201857 Transdermal delivery system for therapeutics
08/09/2012US20120201843 Cyp1b1 nucleic acids and methods of use
08/09/2012US20120201841 Polypeptides and polynucleotides for enhancing immune reactivity to her-2 protein
08/09/2012US20120201763 Novel flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof
08/09/2012US20120201761 Pharmaceutical formulation containing opioid agonist, opioid antagonist and irritant agent
08/09/2012US20120201760 Metal oxide particles coated with polyethylene glycol and their synthesis
08/09/2012US20120201752 Foxc1 antibodies and methods of their use
08/09/2012US20120201748 Coacervate having an ionic polymer mixed with the adhesive protein of a mussel or of a species of the variome thereof
08/09/2012CA2826513A1 Pharmaceutical preparation
08/09/2012CA2826506A1 Compositions and methods for treating chronic inflammation and inflammatory diseases
08/09/2012CA2826452A1 Compositions and methods for treating cardiovascular diseases
08/09/2012CA2826391A1 Pharmaceutical formulations including an amine compound
08/09/2012CA2826362A1 Patch and patch preparation
08/09/2012CA2826218A1 Patch and patch preparation
08/09/2012CA2826217A1 Transdermal patch
08/09/2012CA2826144A1 Foxc1 antibodies and methods of their use
1 ... 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 ... 2991